» Articles » PMID: 28289720

Discerning Functional Hierarchies of MicroRNAs in Pulmonary Hypertension

Overview
Journal JCI Insight
Date 2017 Mar 15
PMID 28289720
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary hypertension (PH) is a multifaceted vascular disease where development and severity are determined by both genetic and environmental factors. Over the past decade, there has been an acceleration of the discovery of molecular effectors that mediate PH pathogenesis, including large numbers of microRNA molecules that are expressed in pulmonary vascular cell types and exert system-wide regulatory functions in all aspects of vascular health and disease. Due to the inherent pleiotropy, overlap, and redundancy of these molecules, it has been challenging to define their integrated effects on overall disease manifestation. In this review, we summarize our current understanding of the roles of microRNAs in PH with an emphasis on potential methods to discern the hierarchical motifs governing their multifunctional and interconnected activities. Deciphering this higher order of regulatory structure will be crucial for overcoming the challenges of developing these molecules as biomarkers or therapeutic targets, in isolation or combination.

Citing Articles

MicroRNA-181 in cardiovascular disease: Emerging biomarkers and therapeutic targets.

Lv B, He S, Li P, Jiang S, Li D, Lin J FASEB J. 2024; 38(9):e23635.

PMID: 38690685 PMC: 11068116. DOI: 10.1096/fj.202400306R.


Pulmonary hypertension.

Mocumbi A, Humbert M, Saxena A, Jing Z, Sliwa K, Thienemann F Nat Rev Dis Primers. 2024; 10(1):1.

PMID: 38177157 DOI: 10.1038/s41572-023-00486-7.


Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice.

Kelly N, Chan S Rev Cardiovasc Med. 2023; 23(11).

PMID: 36875282 PMC: 9980296. DOI: 10.31083/j.rcm2311378.


circ-BPTF serves as a miR-486-5p sponge to regulate CEMIP and promotes hypoxic pulmonary arterial smooth muscle cell proliferation in COPD.

Wang C, Liu Y, Zhang W, Huang J, Jiang J, Wang R Acta Biochim Biophys Sin (Shanghai). 2022; 55(3):438-448.

PMID: 36514216 PMC: 10160238. DOI: 10.3724/abbs.2022178.


The Landscape of Noncoding RNA in Pulmonary Hypertension.

Deng L, Han X, Wang Z, Nie X, Bian J Biomolecules. 2022; 12(6).

PMID: 35740920 PMC: 9220981. DOI: 10.3390/biom12060796.


References
1.
Kang H, Louie J, Weisman A, Sheu-Gruttadauria J, Davis-Dusenbery B, Lagna G . Inhibition of microRNA-302 (miR-302) by bone morphogenetic protein 4 (BMP4) facilitates the BMP signaling pathway. J Biol Chem. 2012; 287(46):38656-64. PMC: 3493910. DOI: 10.1074/jbc.M112.390898. View

2.
Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

3.
Lee C, Mitsialis S, Aslam M, Vitali S, Vergadi E, Konstantinou G . Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012; 126(22):2601-11. PMC: 3979353. DOI: 10.1161/CIRCULATIONAHA.112.114173. View

4.
Chan S, Loscalzo J . Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol. 2007; 44(1):14-30. PMC: 2234575. DOI: 10.1016/j.yjmcc.2007.09.006. View

5.
Gonsalves C, Li C, Malik P, Tahara S, Kalra V . Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease. Biosci Rep. 2015; 35(6). PMC: 4672349. DOI: 10.1042/BSR20150190. View